Article
Impact of Morbid Obesity and Obesity Phenotype on Outcomes After Transcatheter Aortic Valve Replacement.
Journal of the American Heart Association - 15 Jun 2021
McInerney Angela, Tirado-Conte Gabriela, Rodes-Cabau Josep, Campelo-Parada Francisco, Tafur Soto Jose D, Barbanti Marco, Muñoz-Garcia Erika, Arif Mobeena, Lopez Diego, Toggweiler Stefan, Veiga Gabriela, Pylko Anna, Sevilla Teresa, Compagnone Miriam, Regueiro Ander, Serra Viçent, Carnero Manuel, Oteo Juan F, Rivero Fernando, Barbosa Ribeiro Henrique, Guimaraes Leonardo, Matta Anthony, Giraldo Echavarria Natalia, Valvo Roberto, Moccetti Federico, Muñoz-Garcia Antonio J, Lopez-Pais Javier, Garcia Del Blanco Bruno, Campanha Borges Diego Carter, Dumont Eric, Gonzalo Nieves, Criscione Enrico, Dabrowski Maciej, Alfonso Fernando, de la Torre Hernández Jose M, Cheema Asim N, Amat-Santos Ignacio J, Saia Francesco, Escaned Javier, Nombela-Franco Luis
Abstract excerpt
Background There is a paucity of outcome data on patients who are morbidly obese (MO) undergoing transcatheter aortic valve replacement. We aimed to determine their periprocedural and midterm outcomes and investigate the impact of obesity phenotype. Methods and Results Consecutive patients who are MO (body mass index, ≥40 kg/m2, or ≥35 kg/m2 with obesity-related comorbidities; n=910) with severe aortic stenosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.